Dataset Information

Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency.

ABSTRACT: The aim of this retrospective study was to assess respiratory and cardiac function in a large cohort of patients with congenital muscular dystrophies (CMD) with reduced glycosylation of alphadystroglycan (?-DG). Thirteen of the 115 patients included in the study died between the age of 1 month and 20 years. The age at last follow up of the surviving 102 ranged between 1 year and 68 years (median: 9.3 years). Cardiac involvement was found in 7 of the 115 (6%), 5 with dilated cardiomyopathy, 1 cardiac conductions defects and 1 mitral regurgitation. Respiratory function was impaired in 14 (12%). Ten of the 14 required non invasive nocturnal respiratory support, while the other four required invasive ventilation. Cardiac or respiratory involvement was found in patients with mutations in FKRP, POMT1, POMT2. All of the patients in whom mutation in POMGnT1 were identified had normal cardiac and respiratory function.

SUBMITTER: Pane M

PROVIDER: S-EPMC3476532 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency.

Pane M M Messina S S Vasco G G Foley A R AR Morandi L L Pegoraro E E Mongini T T D'Amico A A Bianco F F Lombardo M E ME Scalise R R Bruno C C Berardinelli A A Pini A A Moroni I I Mora M M Toscano A A Moggio M M Comi G G Santorelli F M FM Bertini E E Muntoni F F Mercuri E E

Neuromuscular disorders : NMD 20120622 8

The aim of this retrospective study was to assess respiratory and cardiac function in a large cohort of patients with congenital muscular dystrophies (CMD) with reduced glycosylation of alphadystroglycan (α-DG). Thirteen of the 115 patients included in the study died between the age of 1 month and 20 years. The age at last follow up of the surviving 102 ranged between 1 year and 68 years (median: 9.3 years). Cardiac involvement was found in 7 of the 115 (6%), 5 with dilated cardiomyopathy, 1 car ...[more]

PMID: 22727687

Dataset Information

Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency.

Publications

Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

An atypical expression of core α-Dystroglycan and Laminin-α2 in skin fibroblasts of patients with congenital muscular dystrophies.
| S-EPMC10374774 | biostudies-literature

Muscular dystrophies due to defective glycosylation of dystroglycan.
| S-EPMC2949305 | biostudies-literature

Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of ?-dystroglycan.
| S-EPMC3710768 | biostudies-literature

Congenital muscular dystrophies: a brief review.
| S-EPMC3332154 | biostudies-literature

Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.
| S-EPMC2646259 | biostudies-literature

Diagnostic approach to the congenital muscular dystrophies.
| S-EPMC5258110 | biostudies-literature

Congenital muscular dystrophies involving the O-mannose pathway.
| S-EPMC2855644 | biostudies-literature

FAK deficiency in cells contributing to the basal lamina results in cortical abnormalities resembling congenital muscular dystrophies.
| S-EPMC2758566 | biostudies-literature

Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
| S-EPMC1235559 | biostudies-literature